BRIEF-IDMC starts interim analysis of Mesoblast's phase 3 heart failure trial
March 31, 2017 at 06:30 AM EDT
* Independent Data Monitoring Committee initiates process for interim analysis of Mesoblast’S phase 3 chronic heart failure trial